New Year Bumper Sale @ Rs. 1 X
Glycomet 850 Tablet SR (10), a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes.
The optimal dosage of Glycomet 850 Tablet SR (10) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Glycomet 850 Tablet SR (10) include Stomach Upset, Difficulty urinating. Some other side effects of Glycomet 850 Tablet SR (10) have been listed ahead. Usually, these side effects of Glycomet 850 Tablet SR (10) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Glycomet 850 Tablet SR (10)'s effect during pregnancy is Mild and Moderate while nursing. Further, the section on Glycomet 850 Tablet SR (10) related warnings talks about Glycomet 850 Tablet SR (10)'s effects on the liver, heart and kidney.
Glycomet 850 Tablet SR (10) is contraindicated in people with pre-existing medical conditions like Congestive Heart Failure (CHF), Anemia, Shock as it can result in adverse effects. Other contraindications of Glycomet 850 Tablet SR (10) have been discussed in the sections ahead.
Drug interactions for Glycomet 850 Tablet SR (10) have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Glycomet 850 Tablet SR (10) is considered safe while driving, and is addictive.
Glycomet 850 Tablet SR (10) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Glycomet 850 Tablet SR (10) safe for pregnant women?
Glycomet Tablet rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Glycomet 850 Tablet SR (10) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Glycomet Tablet. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Glycomet 850 Tablet SR (10) on the Kidneys?
Using Glycomet Tablet does not have any harmful effects on kidneys.
What is the effect of Glycomet 850 Tablet SR (10) on the Liver?
Using Glycomet Tablet does not have any harmful effects on the liver.
What is the effect of Glycomet 850 Tablet SR (10) on the Heart?
Glycomet Tablet is completely safe for the heart.
Glycomet 850 Tablet SR (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glycomet 850 Tablet SR (10) unless your doctor advises you to do so -
Is this Glycomet 850 Tablet SR (10) habit forming or addictive?
Glycomet 850 Tablet SR (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Glycomet 850 Tablet SR (10) since it does not cause drowsiness.
Is it safe?
Yes, Glycomet 850 Tablet SR (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Glycomet 850 Tablet SR (10) is unable to treat or cure mental disorders.
Interaction between Food and Glycomet 850 Tablet SR (10)
There isn't any research available on the side effects of taking Glycomet 850 Tablet SR (10) with food.
Interaction between Alcohol and Glycomet 850 Tablet SR (10)
Consuming Glycomet 850 Tablet SR (10) with alcohol can have many serious effects on your body.
Yes, Glycomet Tablet can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with metformin. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia, always keep glucose-rich food with you.
Glycomet Tablet increases the sensitivity of insulin, young women with PCOS often have elevated insulin levels and are more likely to develop diabetes. It is often prescribed for women with PCOS to help prevent diabetes. A lifestyle that includes healthy nutrition and daily exercise is the most important part of a PCOS treatment plan.
Glycomet Tablet should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
Glycomet Tablet helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Glycomet Tablet is not approved for weight loss, this is an off-label use.
No, you should not take alcohol with Glycomet Tablet, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Glycomet Tablet than if you're just taking Glycomet Tablet. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826